David Ebersman

David Ebersman is the CEO of Lyra Health. He was formerly the CFO of Facebook, Inc. Facebook issued an initial public offering (IPO) of its stock on May 18, 2012.[1]

Early life

David Ebersman attended the Trinity School in New York City. David Ebersman graduated from the Trinity School in 1987 and then went on to attend Brown University and graduated from Brown in June 1991.[2] He graduated from Brown with a degree in Economics.[3]

Career

Ebersman began his professional career at Oppenheimer & Co, Inc. in September 1991 as a Research Analyst. Ebersman left Oppenheimer & Co in February 1994 and began working for Genentech. He held the following positions at Genentech from February 1994 until his departure from the company in April 2009:[2]

Genentech positions held:[4]

In September 2009, Mr. Ebersman began his career at Facebook as the company's Chief Financial Officer. Mr. Ebersman was hired by Facebook, in part, because he had "public company experience".[2][5] He was succeeded by David Wehner, who assumed the position on June 1, 2014.

In May 2015, Mr. Ebersman announced the launch of Lyra Health, a health care company that sells technology and services to address mental health.[6]

In July 2015, Mr. Ebersman was appointed to the board of SurveyMonkey.[7]

References

  1. "Going Public: Key Developments in Facebook's IPO - ABC News". Abcnews.go.com. 2012-02-01. Retrieved 2012-05-22.
  2. 1 2 3 "David Ebersman". Facebook. Retrieved 2012-05-22.
  3. David A. Ebersman. "David Ebersman: Executive Profile & Biography - Businessweek". Investing.businessweek.com. Retrieved 2012-05-22.
  4. "David Ebersman – Official webpage for David Ebersman". Davidebersman.com. Retrieved 2012-05-22.
  5. "Facebook hires former Genentech exec as CFO". ZDNet. 2009-06-29. Retrieved 2012-05-22.
  6. "Announcing Lyra Health". Retrieved 2015-06-20.
  7. "Sheryl Sandberg Joins SurveyMonkey's Board". Retrieved 2015-07-06.


This article is issued from Wikipedia - version of the 5/23/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.